Announcements Trials

Browse Landscape

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 5 Observational 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

Blood Specimen Collection 85 Surveys and Questionnaires 83 Surgical Procedures, Operative 44 Drug Therapy 32 Radiotherapy 27 Biopsy 26 Amplified Fragment Length Polymorphism Analysis 24 Neoadjuvant Therapy 23 Immunohistochemistry 22 Gene Expression Profiling 21 Bevacizumab 19 Data Collection 18 Immunotherapy 17 Ultrasonography 16 Positron Emission Tomography Computed Tomography 16 Magnetic Resonance Spectroscopy 16 Liquid Biopsy 16 pembrolizumab 15 Nivolumab 15 Watchful Waiting 14 Radiosurgery 14 Observation 14 Microarray Analysis 14 Magnetic Resonance Imaging 14 Interviews as Topic 14 Immune Checkpoint Inhibitors 13 Colonoscopy 13 Capecitabine 13 Polymerase Chain Reaction 12 Paclitaxel 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Observational × dostarlimab × Clear all

NCT05728814 2024-02-23

DORA

Grupo Español de Investigación en Cáncer de Ovario

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡